Psychologists in Port Chester, NY Accepting Medicare
6 Psychologists found. Showing 1 - 6
 Dr. Bertha Lucia Cruz, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 18 Central Ave, Port Chester, NY 10573 Phone: 914-934-8045 |
 Misael Martinez Psychologist - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 132 Pearl St, Port Chester, NY 10573 Phone: 914-393-2700 |
Dr. Valentina Shehu, PH.D. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 10 Pearl St Fl 2, Port Chester, NY 10573 Phone: 845-279-5908 Fax: 914-653-8282 |
Melvin Walter Crosby, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 377 Westchester Ave, Suite Lj, Port Chester, NY 10573 Phone: 914-937-2280 Fax: 914-937-2280 |
Dr. Wendy Mckenna, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 22 Elizabeth St, Port Chester, NY 10573 Phone: 914-939-9197 |
Sara Lynn Goldsmith, M.A. Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 1 Gateway Plz, Port Chester, NY 10573 Phone: 914-937-2320 Fax: 914-937-3183 |
News Archive
ImmunGene, Cephalon Australia collaborate to advance new class of protein therapeutics
ImmunGene, Inc., a privately held drug development company focused on targeted antibody therapeutics, announced today it has entered into a collaboration in which Cephalon Australia (a wholly owned subsidiary of Cephalon, Inc.) will apply ImmunGene's interferon payload technology to up to six of its new drug targets for cancers.
New technique measures formation of clumps of proteins in protein-based pharmaceuticals
Scientists at the National Institute of Standards and Technology (NIST) have developed a technique to measure the formation of clumps of proteins in protein-based pharmaceuticals.
Risk of coronary heart disease is transferred via genes, not via unhealthy family lifestyle
It has long been known that hereditary factors play a role in coronary heart disease. However, it has been unclear whether the increased risk is transferred through the genes or through an unhealthy lifestyle in the family. A new study from the Center for Primary Health Care Research in Sweden, published in the American Heart Journal, shows that genes appear to be most important.
Regeneron's ARCALYST prevents gout attacks in Phase 3 study of patients initiating allopurinol therapy
Regeneron Pharmaceuticals, Inc. announced that a Phase 3 study in gout patients initiating allopurinol therapy to lower their uric acid levels showed that ARCALYST (rilonacept), also known as IL-1 Trap, prevented gout attacks, as measured by the primary endpoint of the number of gout flares per patient over the 16 week treatment period.
Why advanced bladder cancer still remains as deadly as it was 30 years ago?
Despite research showing that aggressive treatment with surgery, chemotherapy and radiation can extend the lives of and even cure patients with advanced bladder cancer, many don't get it.
› Verified 2 days ago
Clinical Social Workers
Dentists
Counselors
Pharmacists
Occupational Therapists
Psychologists